Health Trials

Small Bowel Bleeding

2

Review clinical trials related to Small Bowel Bleeding. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Post Market Trial Assessing the Accuracy of Normal Mode Reading vs. ProScan Reading With the NaviCam SB System. This is a Comparison of Retrospectively Obtained Capsule Endoscopy Videos With a New AI Reading Tool; no New Interventions Will be Completed.

NaviCam ProScan is an artificial intelligent (AI) assisted reading tool designed to aid small bowel capsule endoscopy reviewers in decreasing the time to review capsule endoscopy images for adult patients in whom the capsule endoscopy images were obtained for suspected small bowel bleeding.

Participants needed: 92
Trial details
Age: 22+Biological sex: AllType: ObservationalSponsor: AnX Robotica Corp.Updated: Jun 8, 2026Locations: 3Duration: 14 Days
Eligibility criteria

Patients of all genders, races, ethnicities and geographical backgrounds, from 2... [+1]

In patients with known or suspected gastrointestinal obstruction, strictures, or... [+10]

Read more
Status: Recruiting

Early Videocapsule Endoscopy for Upper Gastrointestinal Bleeding

The objective of this study is to determine whether early video capsule endoscopy (VCE) immediately after a negative gastroscopy in the setting of suspected upper gastrointestinal bleeding (UGIB) improves patient outcomes as compared to the standard approach which typically involves performing colonoscopy prior to small bowel investigations. We aim to examine the differences in diagnostic yield, total number of procedures, length of hospitalization, mortality rates, and healthcare cost between the two groups.

Participants needed: 70
Trial details
Age: 18-90Biological sex: AllType: InterventionalSponsor: University of AlbertaUpdated: Mar 16, 2026Locations: 1
Eligibility criteria

Age ≥ 18 years [+5]

Inability to provide consent due to lack of capacity, language barrier or other... [+5]

Read more